Arinna Lifesciences Limited - Company Profile

Q: Who are the current directors of Arinna Lifesciences Limited?

The current directors of Arinna Lifesciences Limited are Siddharth Shah, Shankar Gopalakrishnan, Rohit Brijmohan Mantri, Vivek Seth, Shilpa Vivek Seth, Subramaniam Iyer, Astha Premswaroop Kumavat.

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2013.

2013 Ahmedabad, Gujarat, India Active

Last Updated: January 06, 2026

Access Report

About Arinna Lifesciences Limited

Arinna Lifesciences Limited, a active public limited company, was established on 29 August 2013 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230GJ2013PLC076619. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.06 Cr.

Formerly known as Arinna Lifesciences Limited, Arinna Lifesciences Private Limited. It upholds a compliant status. Employing 321 professional, Its leadership includes Siddharth Shah (Director), Shankar Gopalakrishnan (Director), Rohit Brijmohan Mantri (Nominee Director). Past directors included Siddharth Shah, Shankar Gopalakrishnan, Trushit Indravadan Chokshi. It holds ₹9.00 M open charges and ₹6.15 Cr settled loans. Its latest AGM occurred on 15 September 2025, with the balance sheet filed on 31 March 2025. It is based at A- 301 To 307, 3Rd Floor, Sankalp Iconic Tower, Iskcon-Ambli Road, Off. S G Highway, Ahmedabad, Gujarat, 380054.

Company Details

CIN/LLPIN
U24230GJ2013PLC076619
Registration Number
076619
Incorporation Date
29 August 2013
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹13.06 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 06-01-2026
Paid Up Capital ₹ 13.06 Cr as on 06-01-2026
Company Age 12 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 9.00 M as on 06-01-2026
Satisfied Charges ₹ 6.15 Cr as on 06-01-2026
Revenue Growth **** 7.75% (FY 2024)
Profit Growth **** -19.93% (FY 2024)
Ebitda **** 1141.58% (FY 2024)
Net Worth 11.28% (FY 2024)
Total Assets -0.58% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Arinna Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Arinna Lifesciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Siddharth Shah	Director	23 Apr 2015	Current
Shankar Gopalakrishnan	Director	23 Apr 2015	Current
Rohit Brijmohan Mantri	Nominee Director	03 May 2016	Current
Vivek Seth	Managing Director	29 Aug 2013	Current
Shilpa Vivek Seth	Director	29 Aug 2013	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2015	Past
Pramod Abcsdd	Additional Director	30 Sep 2015	Past
Pramod Abcsdd	Director	01 Sep 2016	Past
Pramod Abcsdd	Director	05 Jan 2015	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arinna Lifesciences.

Arinna Lifesciences Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.75% increase. The company also saw a substantial fall in profitability, with a 19.93% decrease in profit. The company's net worth Soared by an impressive increase of 11.28%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.75%

*******

Revenue from Operations

*******

8.44%

*******

Total Assets

*******

-0.58%

*******

Profit or Loss

*******

-19.93%

*******

Net Worth

*******

11.28%

*******

EBITDA

*******

1141.58%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arinna Lifesciences?

In 2024, Arinna Lifesciences had a promoter holding of 38.16% and a public holding of 61.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹9,000,000.00

Satisfied Charges

₹61,500,000.00

Charges Breakdown by Lending Institutions

Others : 0.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
06 Jan 2025	Others	₹9.00 M	Open
01 Apr 2021	Axis Bank Limited	₹3.00 Cr	Satisfied
26 Feb 2018	Axis Bank Limited	₹3.15 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Arinna Lifesciences?

Arinna Lifesciences has a workforce of 321 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Arinna Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arinna Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arinna Lifesciences

Recent Activity within the Organization

Annual General Meeting

Arinna Lifesciences Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records. was recorded as a recent event.
15 Sep 2025
Director Appointment

Astha Premswaroop Kumavat was appointed as a Company Secretary was appointed as a Company Secretary on 28 Jul 2025 & has been associated with this company since 7 months 2 days . was recorded as a recent event.
28 Jul 2025
Balance Sheet

Arinna Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
31 Mar 2025
Charges

The activity A charge registered on 01 Apr 2021 via Charge ID 100439973 with Axis Bank Limited was fully satisfied on 10 Jan 2025. was completed.
10 Jan 2025
Charges

A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101032839 was registered on 06 Jan 2025. was recorded as a recent event.
06 Jan 2025
Director Appointment

The activity Subramaniam Iyer was appointed as a CFO was appointed as a CFO on 17 May 2022 & has been associated with this company since 3 years 9 months . was completed.
17 May 2022

Explore recent activity and updates - View Recent Activity